 |
|
Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea
Bo Hyoung Kang, Kyung-Wook Jo, Tae Sun Shim
Tuberc Respir Dis. 2017;80(2):143-152. Published online 2017 Mar 31 DOI: https://doi.org/10.4046/trd.2017.80.2.143
|
|
Citations to this article as recorded by
 Adverse Drug Reactions with First-Line and Second-Line Drugs in Treatment of Tuberculosis
Rajendra Prasad, Abhijeet Singh, Nikhil Gupta
Annals of the National Academy of Medical Sciences (India).2021; 57(01): 15. CrossRef Age-stratified anti-tuberculosis drug resistance profiles in South Korea: a multicenter retrospective study
Eung Gu Lee, Jinsoo Min, Ji Young Kang, Sung Kyoung Kim, Jin Woo Kim, Yong Hyun Kim, Hyoung Kyu Yoon, Sang Haak Lee, Hyung Woo Kim, Ju Sang Kim
BMC Infectious Diseases.2020;[Epub] CrossRef Adverse drug reactions in tuberculosis and management
Rajendra Prasad, Abhijeet Singh, Nikhil Gupta
Indian Journal of Tuberculosis.2019; 66(4): 520. CrossRef
|